Request more information or explore ordering options to bring Myriad’s prenatal screening solutions into your practice.
Request informationBack
Resources
Request more information about how Myriad’s prenatal screening options can benefit your patients.
Receive a genetic screening patient guide to learn more about your options.
By submitting your personal information, you agree to be contacted with newsletters, marketing or promotional materials, and other information that may be of interest to you. You may opt-out of receiving communications from us by following the unsubscribe link or the instructions provided in the communication we send. For further information on our privacy practices and commitment to protecting your privacy, please visit our Privacy Notice.
Please provided your women’s health provider information (optional)
Contact Information
Help patients of every background and BMI manage their pregnancies with screenings that offer the industry’s lowest failure rate.1
Help patients of every background and BMI manage their pregnancies with screenings that offer the industry’s lowest failure rate1.
Patients depend on you to guide them through all the screening options to manage their future or current pregnancy. The Foresight® Carrier Screen helps identify carriers of inherited health conditions that might be passed on to a child, while the Prequel® Prenatal Screen helps you gather more insight into the health of a current pregnancy and baby.
Learn how Myriad’s prenatal screening can benefit your patients.
As the pioneer of expanded carrier screening and fetal fraction amplification technology, only Myriad has addressed inequity in prenatal screening. Our carrier screen and non-invasive prenatal screen are carefully designed to provide reliable and personalized results for every ancestry and BMI.
Carrier screening can identify couples who are at risk of passing inherited disorders to their children. Foresight elevates quality of care by enabling carrier screening for all patients, regardless of family history or ethnicity.
Identifies at-risk couples
Foresight detects the 1 in 22 couples at-risk for passing serious and actionable conditions to their children2 — the highest published detection rate in the industry.
>99% detection rate for the majority of genes
Be confident in both positive and negative results with >99% detection rates, regardless of ethnicity, for the majority of the genes in the panel.3
Clear results with pre- and post-screen support
We provide clear, user-friendly results as well as access to board-certified genetic counselors for patient education pre-and post-screen.
As early as week eight, Prequel uses cell-free DNA (cfDNA) to determine if a pregnancy is at an increased risk for a chromosome abnormality leading to conditions such as Down, Edwards, or Patau syndromes. These results give your patients more time and information to plan and prepare.
AMPLIFY™ Technology
Prequel is the only prenatal cfDNA screen with revolutionary AMPLIFY technology that increases fetal fraction for everybody1, enabling up to 100% positive predictive values (PPV) for 22q microdeletion detection.5
Answers for patients of all BMIs
With the lowest proven failure rate of 0.1%, Prequel provides reliable and individualized insights for 99.9% of all patients – regardless of BMI.4,6
Individualized results and support
Results that deliver clarity of patients’ true risk with individualized PPV and residual-risk estimates to help inform next steps.
SneakPeek is a gender test that identifies the fetal sex of the baby
FirstGene delivers actionable genetic insights with a simple blood draw as early as 10 weeks gestation.
With Myriad Complete, we support you and your patients throughout the genetic screening process:
These solutions allow for seamless integration of Myriad Genetics’ prenatal screens into your clinical care routines to help patients better understand and benefit from their results.
We’re committed to making prenatal genetic screening accessible for all patients who can benefit. Our financial assistance program takes into account each patient’s ability to pay, working with them directly to find the best option.*